Use of Perioperative Infusion of Lignocaine VS. Dexmedetomidine for Better Outcome in Patients Undergoing General Anaesthesia for Laparoscopic Cholecystectomy: A Randomized Controlled Trial.

Efficacy of Perioperative Infusion of Lignocaine VS. Dexmedetomidine on Recovery Profile in Patients Undergoing Laparoscopic Cholecystectomy. A Randomized Controlled Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043719

Enrollment

Registered

2022-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: Lignocaine: Dose- 1.5MG/KG/HR of continuous lignocaine infusion Duration- Before Induction till end of surgery Control Intervention1: Dexmedetomidine: Dose - 1Âµg/kg/hr continuous de

Eligibility

Inclusion criteria

Inclusion criteria: Patients consent Patients aged between 30-50 years of both the sexes. Patients with ASA Grade I or II. Patients undergoing elective laparoscopic cholecystectomy under General anaesthesia.

Exclusion criteria

Exclusion criteria: Patients refusal. Patients with ASA Grade III or higher. Patients with known Neurological /endocrine/ renal / hepatic/ cardiac diseases Patients on Psychotropic drugs or history of drug allergies

Design outcomes

Primary

Measure	Time frame
RECOVERY PROFILE- Time taken for Return of spontaneous respiration Eyeopening Following Verbal CommandTimepoint: Time taken after giving the reversal agent	—

Secondary

Measure	Time frame
1)PONV 2)POST OPERATIVE PAIN 3) RESCUE ANALGESIA Timepoint: 1 HOUR POST OPERATIVELY	—

Countries

India

Contacts

Public ContactDr Tulika Singh

IGIMSPATNA

tulikasingh12dec@gmail.com9430561186

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026